Medicinal Mushrooms, Blood Thinning, and Traditional Use Notes
Background
A medicinal mushroom complex from Naturalife.ie includes:
- 300mg Lion’s Mane powder
- 300mg Cordyceps powder
- 300mg Reishi powder
The product includes a warning stating that it is not suitable for people taking blood thinners but does not explain the mechanism.
This raised questions about the following:
- whether the warning is based on real evidence or merely legal caution,
- whether there could be interactions with nattokinase and vitamin K2,
- and whether medicinal mushrooms are fundamentally different from ordinary culinary mushrooms.
Evidence for Anti-Coagulant Effects
There is genuine scientific literature suggesting that several medicinal mushrooms can influence platelet aggregation and clotting pathways. This is not purely a legal disclaimer. Research suggests that some mushroom compounds may:
- reduce platelet aggregation,
- affect thromboxane pathways,
- increase fibrinolytic activity,
- or otherwise mildly reduce clot formation.
However, much of the evidence is:
- in vitro (test tube studies),
- animal studies,
- or small-scale human research.
The evidence is much weaker than for pharmaceutical anticoagulants like warfarin.
Mushrooms Commonly Mentioned
Medicinal mushrooms associated with clotting/bleeding cautions include the following:
- Reishi (Ganoderma lucidum)
- Cordyceps (Cordyceps sinensis)
- Chaga (Inonotus obliquus)
- Shiitake (Lentinula edodes)
- Maitake
Lion’s Mane appears less strongly associated with clotting effects, though evidence is limited.
Nattokinase vs Warfarin
Warfarin is in a completely different category from most supplements.
Warfarin:
- directly interferes with the vitamin K cycle,
- significantly alters coagulation pathways,
- and has strong clinically measurable anticoagulant effects.
Nattokinase appears mechanistically different.
Research suggests nattokinase may:
- increase fibrinolysis,
- increase plasmin activity,
- reduce fibrin accumulation,
- and mildly inhibit platelet aggregation.
Some researchers describe it as more “regulatory” than directly anticoagulant, though evidence is still limited compared with pharmaceutical drugs.
Because of this, the main theoretical concern is probably nattokinase + medicinal mushroom extracts = additive mild anti-platelet/fibrinolytic effects. Vitamin K2 is likely much less relevant unless someone is taking warfarin.
Traditional Use vs Supplement Use
Historically, many medicinal mushrooms were not everyday foods.
Examples:
- Reishi
- Chaga
- Cordyceps
These were often:
- rare,
- difficult to prepare,
- used as decoctions or tonics,
- consumed intermittently,
- or prescribed for specific conditions.
Reishi in particular is woody and bitter and traditionally used more as a medicinal tea than as food.
This differs substantially from modern supplement use where people may:
- take concentrated extracts daily,
- combine multiple mushrooms,
- and consume them continuously for years.
Traditional systems often used remedies:
- seasonally,
- cyclically,
- constitutionally,
- or only during illness.
Modern “take every day forever” wellness culture may not reflect traditional usage patterns.
Culinary Mushrooms vs Medicinal Extracts
Ordinary culinary mushrooms likely have much milder physiological effects.
Examples:
- field mushrooms,
- button mushrooms,
- chestnut mushrooms,
- portobellos.
Reasons include:
- lower concentrations of active compounds,
- use as whole foods rather than extracts,
- selection for taste and edibility rather than medicinal potency.
This may be comparable to other ordinary foods with mild biological activity:
- garlic,
- cabbage,
- broccoli,
- turmeric,
- green tea.
These foods can influence physiology, but usually mildly at normal dietary levels.
Modern mushroom supplements differ because they may involve:
- concentrated powders,
- hot-water extracts,
- alcohol extracts,
- standardized beta-glucans,
- concentrated triterpenes.
This can produce effects stronger than ordinary dietary mushroom consumption.
The Dose Perspective
The mushroom complex discussed contains:
- 300mg Lion’s Mane,
- 300mg Cordyceps,
- 300mg Reishi.
These are not especially large doses by supplement standards. Many studies use 1–3 grams daily, or concentrated extract equivalents. Fresh mushrooms are mostly water, so dried powders are already concentrated relative to raw mushrooms.
However, many supplements still rely partly on “capsule mystique”—the perception that encapsulated powders are inherently highly potent. Actual physiological effects likely vary greatly depending on:
- extraction method,
- concentration,
- mushroom species,
- and individual sensitivity.
Individual Sensitivity
Potential subjective effects may be more noticeable in practice than clotting effects. Examples reported anecdotally:
- Reishi → headaches or sedation
- Cordyceps → stimulation or restlessness
- Lion’s Mane → occasional neurological or mood-related reactions in sensitive individuals
Responses appear highly individual.
Practical Interpretation
A moderate interpretation might be:
- ordinary culinary mushroom consumption is unlikely to meaningfully affect clotting,
- medicinal mushroom extracts may have mild anti-platelet or fibrinolytic properties,
- combining multiple such agents continuously may plausibly produce additive effects,
- nattokinase is probably more relevant than vitamin K2 in this context,
- and alternating nattokinase with medicinal mushroom supplementation may reduce theoretical overlap.
This does not appear comparable in magnitude to pharmaceutical anticoagulants such as warfarin.
References
- MDPI review on edible mushrooms and platelet aggregation
- Study on shiitake compound lenthionine and platelet aggregation
- Cordyceps polysaccharide anti-platelet study (PubMed)
- Study including Chaga anti-platelet activity
- Nattokinase and platelet/thrombus research
Sidenote:
Evolutionary Origin of Bioactive Compounds
Many biologically active compounds found in plants, fungi, and other organisms likely evolved primarily as defensive or competitive chemicals, rather than being “designed” for human medicinal use.
Fungi in particular cannot rely on physical defence, so they produce a wide range of secondary metabolites, including:
- neuroactive compounds
- enzyme inhibitors
- immune-modulating polysaccharides
- antimicrobial and anti-competitive chemicals
These compounds may serve ecological roles such as:
- deterring insects or grazing animals
- inhibiting competing microbes or fungi
- altering feeding or reproductive behaviour in predators
- disrupting essential biological pathways in other organisms
Some of these same mechanisms can also affect human physiology, including:
- nervous system signalling
- inflammatory pathways
- platelet function and blood clotting
This creates overlap between:
- toxins (at higher doses or uncontrolled exposure)
- medicines (at controlled doses or refined extracts)
- dietary components (at low levels in whole foods)
A recurring pattern in pharmacology is that many useful drugs originate from these natural defence systems, where biological activity is later repurposed rather than originally evolved for therapeutic use in humans.
In this sense, the distinction between food, medicine, and toxin is often dose- and context-dependent rather than absolute.